Key result
Bioprosthetic valve thrombosis is a major cause of bioprosthetic valve degeneration, but conclusive evidence-based recommendations for its prevention and treatment with anticoagulation are lacking.
Design
Review
Authors
Loading...
Lack of evidence-based anticoagulation guidance advises against routine practice changes; leaves open optimal prevention strategies for prospective trials.
This review highlights the increasing recognition of bioprosthetic valve thrombosis, especially post-TAVR, and underscores the need for further research to establish optimal antithrombotic strategies.
Sachdev et al. (2018) conducted a review in Bioprosthetic Valve Thrombosis. Bioprosthetic valve thrombosis is a major cause of bioprosthetic valve degeneration, but conclusive evidence-based recommendations for its prevention and treatment with anticoagulation are lacking.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: